These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13847797)

  • 21. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 23. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
    NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 25. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of Zymosan on the properdin level of tumor patients].
    NAGY S; HARTAI F
    Acta Biol Med Ger; 1961; 6():99-102. PubMed ID: 13727492
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 28. THE INFLUENCE OF ISOLATED PROPERDIN ON HELA-AND DETROIT 6-CELLS IN VITRO.
    RERABKOVA E; RYBAK M; PETAKOVA M; PESKOVA D
    Blut; 1964; 10():371-82. PubMed ID: 14281008
    [No Abstract]   [Full Text] [Related]  

  • 29. [EFFECT OF ZYMOSAN AND ITS FRACTIONS ON THE PROPERDIN LEVEL IN THE BLOOD AND ON THE MORPHOLOGY OF ORGANS AND TISSUES].
    RUTBERG RA; LOSEVA GI; NEMONOVA NM; MALANINA VN
    Biull Eksp Biol Med; 1964 Apr; 13():127-32. PubMed ID: 14248407
    [No Abstract]   [Full Text] [Related]  

  • 30. [PROPERDIN AND ANAPHYLATOXIN].
    WILLEMS G
    Rev Immunol Ther Antimicrob; 1963; 27():285-90. PubMed ID: 14111198
    [No Abstract]   [Full Text] [Related]  

  • 31. [OBSERVATION ON TUMORAL IMMUNITY IN CONNECTION WITH THE PROPERDIN SYSTEM].
    NAGY IS; ATS M; KOSZORU M; LUST I
    Sangre (Barc); 1964; 17():272-4. PubMed ID: 14218362
    [No Abstract]   [Full Text] [Related]  

  • 32. [Properdin titer following zymosan vaccination in cattle].
    ZIMMERMANN G; HARM M; SCHUTZLER H
    Acta Biol Med Ger; 1963; 10():426. PubMed ID: 14003717
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON THE INTERRELATIONSHIP BETWEEN THE BLOOD PROPERDIN LEVEL, ANTISTREPTOLYSIN TITER, LEUKOCYTE COUNT AND ERYTHROCYTE SEDIMENTATION RATE IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS PATIENTS].
    MATJEW M; TOSZKOW A
    Reumatologia; 1963; 1():25-7. PubMed ID: 14184247
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in serum properdin levels following injection of Zymosan.
    PILLEMER L; ROSS OA
    Science; 1955 May; 121(3151):732-3. PubMed ID: 14372981
    [No Abstract]   [Full Text] [Related]  

  • 35. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ULTRACENTRIFUGE STUDIES ON PROPERDIN SERA OF ZYMOSAN-VACCINATED CATTLE, RABBITS, GUINEA PIGS, RATS AND MICE AND ON BOVINE PROPERDIN SERUM FRACTIONS].
    ZIMMERMANN G; KRUEGER K
    Acta Biol Med Ger; 1963; 11():902-17. PubMed ID: 14121884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Modification of serum properdin activity by nonspecific stimulant drugs in animal experiment].
    von GRAEVENITZ ; HUSMANN KH
    Arzneimittelforschung; 1960 Mar; 10():184-5. PubMed ID: 13828740
    [No Abstract]   [Full Text] [Related]  

  • 38. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.
    PILLEMER L; LANDY M; SHEAR MJ
    J Exp Med; 1957 Jul; 106(1):99-110. PubMed ID: 13439118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the problem of nonspecific reaction of the body to the administration of the polysaccharide zymosan].
    SAMOILINA NL
    Probl Gematol Pereliv Krovi; 1961 Jan; 6():23-30. PubMed ID: 13745936
    [No Abstract]   [Full Text] [Related]  

  • 40. Response of host organism on Zymosan application. (A clinical study).
    Cron J
    Neoplasma; 1970; 17(6):613-9. PubMed ID: 5507475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.